The SMC decision regarding Migalastat (Galafold) was announced on 7 November 2016. The relevant Detailed Advice Document can be found here.
The October 2016 Fabry Newsletter is now available and can be downloaded here.
Please submit your email address to receive our next newsletter.
It is with the heaviest of hearts that we announce the death of Mrs Christine Lavery MBE, Chief Executive of the MP… twitter.com/i/web/status/94381…
December 21, 2017 11:57 am
The latest Fabry Outcome Survey has been published. Read the key highlights from the annual report
November 8, 2017 12:48 pm
Fabry International Network © 2013 - All rights reserved